<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Sequential Use of OnabotulinumtoxinA and Erenumab in Chronic Migraine: Real-World Evidence from a Retrospective Cohort

Simple item page
dc.contributor.authorHoehne, Carolin
dc.contributor.authorSahin, Aysenur
dc.contributor.authorOvereem, Lucas Hendrik
dc.contributor.authorLange, Kristin Sophie
dc.contributor.authorFitzek, Mira Pauline
dc.contributor.authorAngerhoefer, Cornelius
dc.contributor.authorReuter, Uwe
dc.contributor.authorRaffaelli, Bianca
dc.date.accessioned2026-11-05T11:02:07Z
dc.date.issued2025
dc.description.pages329-330
dc.description.volume45
dc.identifier.issn0333-1024
dc.identifier.issn1468-2982
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/10860
dc.identifier.wosWOS:001677707303138
dc.language.isoen
dc.publisherSAGE PUBLICATIONS LTD
dc.relation.conference22nd International Headache Congress (IHC)
dc.relation.ispartofCEPHALALGIA
dc.subjectClinical Neurology
dc.subjectNeurosciences
dc.subjectNeurosciences & Neurology
dc.titleSequential Use of OnabotulinumtoxinA and Erenumab in Chronic Migraine: Real-World Evidence from a Retrospective Cohort
dc.typeMeeting Abstract
oaire.citation.editionScience Citation Index Expanded (SCI-EXPANDED)
oaire.citation.editionConference Proceedings Citation Index - Science (CPCI-S)
oaire.citation.endPage330
oaire.citation.startPage329
oaire.citation.volume45
person.identifier.ridAEO-1579-2022
person.identifier.ridNUQ-4535-2025
person.identifier.ridHKO-6313-2023
person.identifier.ridOZF-6851-2025
person.identifier.ridHLG-6096-2023
person.identifier.ridNKP-2341-2025
person.identifier.ridPGN-0519-2026

Files

Collections

WOS